Apply on Employer Site

Rigel Pharmaceuticals Inc. · 2 weeks ago

Director, Commercial & Promotional Analytics

South San Francisco, CA

Full-time

Onsite

Director/Executive

$217K/yr - $260K/yr

10+ years exp

Rigel Pharmaceuticals Inc. is a biopharmaceutical company focused on innovative therapies. The Director, Commercial and Promotional Analytics will lead the strategy, design, and execution of analytics to enhance decision-making across the commercial portfolio, optimizing brand performance and promotional effectiveness.

BiotechnologyHealth CarePharmaceuticalTherapeutics

Responsibilities

Lead development of data-driven insights to inform brand, franchise, and commercial strategy

Partner with Marketing and cross-functional partners (including Market Access) to establish annual business analytics plans

Oversee KPI and performance tracking dashboards to evaluate market trends, brand health, and promotional effectiveness

Design and execute analytics projects including HCP and patient segmentation, customer journey analyses, support of the forecasting team, and sampling optimization

Collaborate on New Product Planning to assess market opportunities, competitive dynamics, and patient populations for pipeline and early-stage assets

Develop pre-launch analytics frameworks to inform go-to-market planning, resource allocation, and launch readiness assessments

Synthesize complex data into actionable insights that drive strategic recommendations for leadership

Develop and maintain Marketing Mix models to measure and optimize promotional ROI across channels

Partner cross-functionally to define and monitor campaign performance metrics

Integrate advanced analytics capabilities (AI, machine learning, predictive modeling) to identify opportunities for dynamic targeting and next-best action

Partner with Data Operations to evaluate and implement new data sources (e.g., IQVIA, Symphony, MMIT, EMR, Lab data) and methodologies to enhance commercial decision-making

Support launch readiness efforts by providing insight into field deployment, promotional investment optimization, and launch KPI tracking

Collaborate with Forecasting and Brand leads to inform launch performance projections and scenario planning

Serve as a strategic thought partner to leaders across Commercial Strategy, Marketing, and other commercial teams

Translate analytical findings into clear, compelling narratives for executive stakeholders

Manage external analytics and consulting partners to ensure high-quality project delivery

Represent Commercial Analytics in cross-functional planning processes and business reviews

Partner closely with cross-functional Launch Teams and New Product Planning to align analytics deliverables with early commercial strategies, ensuring data-driven launch readiness

Qualification

Commercial analyticsMarketing Mix modelsAdvanced analyticsPharmaceutical data assetsAnalytical toolsBusiness acumenInfluencing skillsNew Product PlanningVendor managementCommunication skills

Required

Bachelor's degree in a quantitative, business, or healthcare-related field (e.g., Economics, Statistics, Business, Life Sciences)

10–12+ years (Director) of experience in commercial analytics, marketing science, or business insights within the biopharmaceutical industry

Demonstrated ability to synthesize diverse data sources into strategic guidance and actionable insights

Expertise with pharmaceutical data assets (IQVIA, Symphony, MMIT, SHA, EMR, Lab data)

Advanced proficiency with analytical and visualization tools (Excel, Tableau, Power BI, SQL, Databricks)

Strong business acumen, communication, and influencing skills

Preferred

MBA or Master's degree preferred

Understanding of rare disease, oncology, payer and managed market dynamics is a plus

Experience supporting New Product Planning, launch analytics, or early commercial strategy is highly desirable

Management of external vendors

Company

Rigel Pharmaceuticals Inc.

Rigel Pharmaceuticals, Inc., is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with hematologic disorders and cancer.

Founded in 1996

South San Francisco, California, USA

51-200 employees